Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination: A cross-sectional study
Patients with underlying medical conditions are at high risk of developing serious symptoms
of the coronavirus disease 2019 than healthy individuals; therefore, it is necessary to …
of the coronavirus disease 2019 than healthy individuals; therefore, it is necessary to …
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
SARS-CoV-2 lipid nanoparticle mRNA vaccines continue to be administered as the
predominant prophylactic measure to reduce COVID-19 disease pathogenesis. Quantifying …
predominant prophylactic measure to reduce COVID-19 disease pathogenesis. Quantifying …
Anti-SARS-CoV-2 antibody level is associated with a history of COVID-19 infection and mRNA vaccination in patients with diabetes
IAH Hataul, NNM Soetedjo, J Debora, MR Tiara… - Vaccines, 2023 - mdpi.com
Type 2 diabetes mellitus (T2DM) is associated with higher severity and mortality in SARS-
CoV-2 infections. Vaccination has been encouraged to boost immunity and prevent these …
CoV-2 infections. Vaccination has been encouraged to boost immunity and prevent these …
[HTML][HTML] Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases
L Yang, LF Xu, Q Guo, B Deng, Y Hong… - … Journal of Medical …, 2023 - ncbi.nlm.nih.gov
Purpose: The effectiveness of inactivated vaccines against acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2), the causative agent of coronavirus disease 2019 (COVID-19) …
coronavirus 2 (SARS‑CoV‑2), the causative agent of coronavirus disease 2019 (COVID-19) …
The impact of comorbidity status in COVID-19 vaccines effectiveness before and after SARS-CoV-2 omicron variant in northeastern Mexico: a retrospective multi …
ME Camacho-Moll, VL Mata-Tijerina… - Frontiers in Public …, 2024 - frontiersin.org
Introduction The end of the coronavirus disease 2019 (COVID-19) pandemic has been
declared by the World Health Organization on May 5, 2023. Several vaccines were …
declared by the World Health Organization on May 5, 2023. Several vaccines were …
[HTML][HTML] Antibody levels versus vaccination status in the outcome of older adults with COVID-19
S Mink, CH Saely, A Leiherer, P Reimann, M Frick… - JCI …, 2024 - pmc.ncbi.nlm.nih.gov
BACKGROUND Despite the currently prevailing, milder Omicron variant of COVID-19, older
adults remain at elevated risk of hospital admission, critical illness, and death. Loss of …
adults remain at elevated risk of hospital admission, critical illness, and death. Loss of …
Neutralizing antibody and T-cell responses against SARS-CoV-2 wild-type and variants of concern in chronic obstructive pulmonary disease subjects after ChAdOx-1 …
W Chaiwong, N Takheaw, W Laopajon, S Pata… - Vaccines, 2022 - mdpi.com
Data on immunogenicity of adenovirus-vectored vaccine in chronic obstructive pulmonary
disease (COPD) patients is limited. Therefore, we aimed to determine the humoral and …
disease (COPD) patients is limited. Therefore, we aimed to determine the humoral and …
The Prevalence and Determinants of Hesitancy for Regular COVID-19 Vaccination among Primary Healthcare Patients with Asthma or COPD in Greece: A Cross …
I Bouloukaki, A Christodoulakis… - Vaccines, 2024 - mdpi.com
The emergence of novel coronavirus mutations and signs of the waning immunity provided
by COVID-19 vaccines underscore the importance of regular vaccination. This study aimed …
by COVID-19 vaccines underscore the importance of regular vaccination. This study aimed …
[HTML][HTML] Follow-up of SARS-CoV-2 antibody levels in Belgian nursing home residents and staff two, four and six months after primary course BNT162b2 vaccination
E Meyers, L De Rop, F Engels, C Gioveni, A Coen… - Vaccines, 2024 - mdpi.com
When COVID-19 vaccines were implemented, nursing home residents (NHRs) and staff
(NHS) in Belgium were prioritized for vaccination. To characterize the vaccine response over …
(NHS) in Belgium were prioritized for vaccination. To characterize the vaccine response over …
Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic …
W Chaiwong, N Takheaw, S Pata, W Laopajon… - Vaccine, 2023 - Elsevier
Background Data on humoral and cellular immune responses against SARS-CoV-2 after
receiving heterologous CoronaVac/ChAdOx-1 (CoVac/ChAd) vaccination in subjects with …
receiving heterologous CoronaVac/ChAdOx-1 (CoVac/ChAd) vaccination in subjects with …